This article was originally published in The Gray Sheet
Executive SummaryE-Z-EM subsidiary receives the CE mark for its AngioStent peripheral stent. The Queensbury, New York-based firm highlights the ability of its stent to be removed "through a sheath if the placement is less than optimal," rather than having to employ "higher risk, open surgical methods"
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.